European heart journal. Cardiovascular Imaging · 2025
Cardiovascular magnetic resonance to differentiate veteran athlete's heart with cavity dilatation and mild dilated cardiomyopathy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Javed Wasim, Tomoaia Raluca, Farooq Maryum, Chambers Bradley, Botis Ioannis, Goh Ze M, Brown Benjamin, Brown Louise A E, Farley Jonathan, Xue Hui, Levelt Eylem, Dall'Armellina Erica, Greenwood John P, Kellman Peter, Plein Sven, Swoboda Peter P
Аннотация
AIMS: This study aimed to investigate the distribution of myocardial fibrosis and patterns of tissue characteristics on cardiovascular magnetic resonance (CMR) between athletes with left ventricular (LV) dilatation and mild dilated cardiomyopathy (DCM) patients.
METHODS AND RESULTS: We prospectively recruited male cyclists/triathletes aged ≥50 years who undertook ≥10 h/week of exercise for ≥15 years along with age-/sex-matched patients with non-ischaemic heart failure (HF). Participants underwent clinical assessment, 12-lead ECG, stress-perfusion CMR with fibrosis assessment, and parametric tissue mapping.Following CMR, included participants in both groups had left ventricular ejection fraction (LVEF) > 40% and left ventricular end-diastolic volume indexed to body surface area (LVEDVi) ≥ 110 mL/m2 without ischaemic heart disease or significant cardiac pathology on CMR likely to cause HF. Of 113 participants (64 athletes and 49 mild DCM patients), athletes with fibrosis demonstrated a greater prevalence of inferolateral fibrosis (87.5% vs. 50.0%, P = 0.002), whereas inferoseptal fibrosis was more common in mild DCM patients (45.8% vs. 9.4%, P = 0.002). Native T1 (1249.0 ± 38.1 vs. 1308.3 ± 47.1 ms, P < 0.001) and extracellular volume (ECV) (22.0 ± 2.1 vs. 25.9 ± 3.5%, P < 0.001) were lower in athletes. Athletes had greater right ventricular end-diastolic volume indexed to body surface area (RVEDVi) (121.0 ± 14.3 vs. 97.6 ± 25.2%, P < 0.001), myocardial perfusion reserve (MPR) (3.65 ± 1.30 vs. 2.76 ± 0.92, P < 0.001), and stress myocardial blood flow (MBF) (2.09 ± 0.70 vs. 1.62 ± 0.66, P < 0.001) than mild DCM patients. On receiver-operator curve analysis, native T1 [area under the curve (AUC) 0.89, P < 0.001], ECV (AUC 0.85, P < 0.001), RVEDVi (AUC 0.81, P < 0.001), and stress MBF (AUC 0.68, P = 0.002) were able to differentiate between groups.
CONCLUSION: Septal fibrosis is rare amongst veteran athletes with LV dilation in contrast to mild DCM patients. Native T1, ECV, and RVEDVi can also discriminate between these overlapping phenotypes, which may be clinically useful.
METHODS AND RESULTS: We prospectively recruited male cyclists/triathletes aged ≥50 years who undertook ≥10 h/week of exercise for ≥15 years along with age-/sex-matched patients with non-ischaemic heart failure (HF). Participants underwent clinical assessment, 12-lead ECG, stress-perfusion CMR with fibrosis assessment, and parametric tissue mapping.Following CMR, included participants in both groups had left ventricular ejection fraction (LVEF) > 40% and left ventricular end-diastolic volume indexed to body surface area (LVEDVi) ≥ 110 mL/m2 without ischaemic heart disease or significant cardiac pathology on CMR likely to cause HF. Of 113 participants (64 athletes and 49 mild DCM patients), athletes with fibrosis demonstrated a greater prevalence of inferolateral fibrosis (87.5% vs. 50.0%, P = 0.002), whereas inferoseptal fibrosis was more common in mild DCM patients (45.8% vs. 9.4%, P = 0.002). Native T1 (1249.0 ± 38.1 vs. 1308.3 ± 47.1 ms, P < 0.001) and extracellular volume (ECV) (22.0 ± 2.1 vs. 25.9 ± 3.5%, P < 0.001) were lower in athletes. Athletes had greater right ventricular end-diastolic volume indexed to body surface area (RVEDVi) (121.0 ± 14.3 vs. 97.6 ± 25.2%, P < 0.001), myocardial perfusion reserve (MPR) (3.65 ± 1.30 vs. 2.76 ± 0.92, P < 0.001), and stress myocardial blood flow (MBF) (2.09 ± 0.70 vs. 1.62 ± 0.66, P < 0.001) than mild DCM patients. On receiver-operator curve analysis, native T1 [area under the curve (AUC) 0.89, P < 0.001], ECV (AUC 0.85, P < 0.001), RVEDVi (AUC 0.81, P < 0.001), and stress MBF (AUC 0.68, P = 0.002) were able to differentiate between groups.
CONCLUSION: Septal fibrosis is rare amongst veteran athletes with LV dilation in contrast to mild DCM patients. Native T1, ECV, and RVEDVi can also discriminate between these overlapping phenotypes, which may be clinically useful.